Afinitor (everolimus)

pCPA File Number: 20802
Negotiation Status:
Negotiations were not pursued
Indication(s):
Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex (TSC)
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0315-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: